HAOXIANGNI HEALTH FOOD CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.25 CNY | -5.30% |
|
+0.81% | -18.51% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,878 | 4,327 | 6,515 | 3,856 | 4,215 | 3,476 |
| Enterprise Value (EV) 1 | 4,213 | 4,806 | 3,534 | 2,121 | 2,914 | 2,566 |
| P/E ratio | 30.1 x | 22.1 x | 3.03 x | 66.9 x | -22.1 x | -63.9 x |
| Yield | 1.05% | 1.03% | 7.7% | 1.15% | 1.05% | - |
| Capitalization / Revenue | 0.78 x | 0.73 x | 2.17 x | 3.01 x | 3.01 x | 2.01 x |
| EV / Revenue | 0.85 x | 0.81 x | 1.18 x | 1.66 x | 2.08 x | 1.48 x |
| EV / EBITDA | 16.5 x | 20.9 x | -31.7 x | 182 x | -19.2 x | 61.9 x |
| EV / FCF | 39.6 x | -6,170 x | 18.8 x | -9.18 x | -15.7 x | 6.17 x |
| FCF Yield | 2.53% | -0.02% | 5.32% | -10.9% | -6.36% | 16.2% |
| Price to Book | 1.16 x | 1.24 x | 1.18 x | 0.87 x | 1 x | 0.8 x |
| Nbr of stocks (in thousands) | 515,684 | 515,684 | 501,942 | 443,235 | 443,235 | 453,243 |
| Reference price 2 | 7.520 | 8.390 | 12.98 | 8.700 | 9.510 | 7.670 |
| Announcement Date | 4/18/19 | 4/24/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4,949 | 5,961 | 3,001 | 1,281 | 1,400 | 1,728 |
| EBITDA 1 | 255.2 | 230 | -111.4 | 11.63 | -152 | 41.47 |
| EBIT 1 | 128.3 | 100.1 | -240.2 | -95.02 | -266.9 | -70.74 |
| Operating Margin | 2.59% | 1.68% | -8% | -7.42% | -19.06% | -4.09% |
| Earnings before Tax (EBT) 1 | 152.9 | 239.3 | 2,912 | 66.68 | -234.2 | -50.78 |
| Net income 1 | 129.6 | 192.6 | 2,155 | 61.63 | -189.7 | -51.89 |
| Net margin | 2.62% | 3.23% | 71.8% | 4.81% | -13.55% | -3% |
| EPS 2 | 0.2500 | 0.3800 | 4.290 | 0.1300 | -0.4300 | -0.1200 |
| Free Cash Flow 1 | 106.5 | -0.7788 | 188 | -231 | -185.3 | 415.8 |
| FCF margin | 2.15% | -0.01% | 6.26% | -18.03% | -13.23% | 24.06% |
| FCF Conversion (EBITDA) | 41.71% | - | - | - | - | 1,002.62% |
| FCF Conversion (Net income) | 82.17% | - | 8.72% | - | - | - |
| Dividend per Share 2 | 0.0790 | 0.0860 | 1.000 | 0.1000 | 0.1000 | - |
| Announcement Date | 4/18/19 | 4/24/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 8.568 |
| Net margin | - |
| EPS 2 | 0.0200 |
| Dividend per Share | - |
| Announcement Date | 4/28/22 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 335 | 479 | - | - | - | - |
| Net Cash position 1 | - | - | 2,981 | 1,735 | 1,301 | 911 |
| Leverage (Debt/EBITDA) | 1.314 x | 2.083 x | - | - | - | - |
| Free Cash Flow 1 | 106 | -0.78 | 188 | -231 | -185 | 416 |
| ROE (net income / shareholders' equity) | 3.29% | 5.66% | 48.3% | 1.11% | -4.71% | -1.36% |
| ROA (Net income/ Total Assets) | 1.5% | 1.05% | -2.38% | -1.01% | -3.11% | -0.81% |
| Assets 1 | 8,642 | 18,410 | -90,731 | -6,083 | 6,105 | 6,369 |
| Book Value Per Share 2 | 6.480 | 6.780 | 11.00 | 10.00 | 9.510 | 9.560 |
| Cash Flow per Share 2 | 1.300 | 1.070 | 3.340 | 3.870 | 2.880 | 3.330 |
| Capex 1 | 342 | 347 | 102 | 195 | 130 | 88.6 |
| Capex / Sales | 6.9% | 5.83% | 3.4% | 15.2% | 9.28% | 5.12% |
| Announcement Date | 4/18/19 | 4/24/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.51% | 391M | |
| +22.30% | 792M | |
| -28.09% | 415M |
- Stock Market
- Equities
- 002582 Stock
- Financials Haoxiangni Health Food Co.,Ltd.
